{"result": {"id": "9d2f8894-39fd-4697-a267-ef9126cf2d96", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Irbesartan Research Community\",\n    \"summary\": \"The community centers around the study of Irbesartan, a medication investigated for its renoprotective effects in patients with diabetic nephropathy. Key entities include researchers CLARKE WR, LEWIS EJ, HUNSICKER LG, and a group of Chinese researchers (ZONG WENYI, YANG WENYING, XIANG HONGDING), all contributing to the understanding of Irbesartan's therapeutic potential. The community's structure is defined by collaborative research efforts and publications, notably in the N Engl J Med journal.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the potential for significant advancements in treating diabetic nephropathy.\",\n    \"findings\": [\n        {\n            \"summary\": \"Irbesartan's central role in the community\",\n            \"explanation\": \"Irbesartan is the focal point of the community, with research efforts aimed at understanding its renoprotective effects in diabetic nephropathy patients. Its significance is underscored by its publication in the N Engl J Med journal, indicating high-quality research and potential for widespread impact. [Data: Entities (1327), Relationships (1113)]\"\n        },\n        {\n            \"summary\": \"Key researchers and their contributions\",\n            \"explanation\": \"Researchers like CLARKE WR, LEWIS EJ, and HUNSICKER LG have made substantial contributions to the study of Irbesartan's effects on diabetic nephropathy. Their collaborative efforts, as evidenced by co-authorship on studies, highlight a shared focus on advancing treatment options for diabetic kidney disease. [Data: Entities (1331, 1329, 1330), Relationships (1116, 4674, 4677)]\"\n        },\n        {\n            \"summary\": \"International collaboration in research\",\n            \"explanation\": \"The involvement of Chinese researchers (ZONG WENYI, YANG WENYING, XIANG HONGDING) in studying Irbesartan for type 2 diabetes indicates an international effort to understand and mitigate the effects of diabetic nephropathy. This global perspective enriches the community's research and potential impact. [Data: Entities (1350, 1351, 1352), Relationships (1117, 1118, 1119)]\"\n        },\n        {\n            \"summary\": \"Publication in prestigious journals\",\n            \"explanation\": \"The study on Irbesartan and diabetic nephropathy being published in the N Engl J Med journal signifies the research's credibility and potential to influence clinical practices. This publication serves as a cornerstone for the community's findings and future directions. [Data: Relationships (1113)]\"\n        },\n        {\n            \"summary\": \"Focus on diabetic nephropathy\",\n            \"explanation\": \"The community's research is predominantly focused on diabetic nephropathy, a common and serious complication of type 2 diabetes. This focus underscores the urgency and importance of finding effective treatments to protect kidney function in affected patients. [Data: Entities (1327, 1331, 1329, 1330), Relationships (1116, 4674, 4677)]\"\n        }\n    ]\n}", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752168674, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 671, "prompt_tokens": 2939, "total_tokens": 3610, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1472}, "prompt_cache_hit_tokens": 1472, "prompt_cache_miss_tokens": 1467}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            },\n            {\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }\n        ]\n    }\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nLimit the total report length to 2000 words.\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        },\n        {\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        },\n        {\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        },\n        {\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }\n    ]\n}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\r\n1327,IRBESARTAN,\"A medication studied for its effect on diabetic nephropathy\"\"\",10\r\n1331,CLARKE WR,\"**CLARKE WR** is a researcher who has been involved in studies investigating the renoprotective effects of irbesartan, particularly in patients with nephropathy resulting from type 2 diabetes. The research focuses on assessing how irbesartan, an angiotensin II receptor blocker, may help protect kidney function in this high-risk patient population. Both descriptions highlight CLARKE WR's contribution to understanding the therapeutic potential of irbesartan in mitigating kidney damage associated with diabetic nephropathy. The consistent emphasis on renoprotection suggests a specialized interest in cardiovascular and renal outcomes in diabetes.  \n\nThe summaries align without contradiction, reinforcing CLARKE WR's role in this specific area of medical research. The work underscores the importance of targeted therapies, such as irbesartan, in managing complications of type 2 diabetes. No discrepancies were found between the provided descriptions, resulting in a coherent overview of the researcher's focus.  \n\n(Word count: 149)\",3\r\n1350,ZONG WENYI,\"Researcher involved in the Chinese study on irbesartan for type 2 diabetes\"\"\",1\r\n1351,YANG WENYING,\"Researcher involved in the Chinese study on irbesartan for type 2 diabetes\"\"\",1\r\n1352,XIANG HONGDING,\"Researcher involved in the Chinese study on irbesartan for type 2 diabetes\"\"\",1\r\n1329,LEWIS EJ,\"**LEWIS EJ** is a researcher known for his involvement in studies investigating the renoprotective effects of irbesartan, particularly in patients with nephropathy caused by type 2 diabetes. His work focuses on evaluating how irbesartan, an angiotensin II receptor blocker, can protect kidney function and slow the progression of kidney disease in diabetic patients. The research highlights the potential therapeutic benefits of irbesartan in managing diabetic nephropathy, a common complication of type 2 diabetes. Both descriptions emphasize his contribution to this specific area of study, underscoring the consistency and significance of his findings.  \n\nIn summary, LEWIS EJ's research centers on the renoprotective properties of irbesartan, with a clear emphasis on its application for patients suffering from type 2 diabetes-related nephropathy. His work contributes to a deeper understanding of treatment options for diabetic kidney disease.\",4\r\n1330,HUNSICKER LG,\"**HUNSICKER LG** is a researcher primarily known for their involvement in studies examining the renoprotective effects of irbesartan, particularly in patients with nephropathy resulting from type 2 diabetes. Their work focuses on investigating how irbesartan, an angiotensin II receptor blocker, may help protect kidney function in this high-risk patient population. The research underscores the potential therapeutic benefits of irbesartan in slowing the progression of diabetic nephropathy, a common complication of type 2 diabetes. Both descriptions highlight HUNSICKER LG's contribution to this specific area of study, emphasizing a consistent focus on the drug's renoprotective properties. No contradictions were found between the provided descriptions, as they collectively reinforce the researcher's dedication to understanding irbesartan's role in managing diabetic kidney disease.\",3\r\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\r\n1113,IRBESARTAN,N ENGL J MED,The study on irbesartan and diabetic nephropathy was published in the N Engl J Med journal,19\r\n1116,IRBESARTAN,CLARKE WR,Clarke WR studied the renoprotective effect of irbesartan,13\r\n1117,IRBESARTAN,ZONG WENYI,Zong Wenyi studied irbesartan for type 2 diabetes,11\r\n1118,IRBESARTAN,YANG WENYING,Yang Wenying studied irbesartan for type 2 diabetes,11\r\n1119,IRBESARTAN,XIANG HONGDING,Xiang Hongding studied irbesartan for type 2 diabetes,11\r\n4674,LEWIS EJ,HUNSICKER LG,Co-authors on a study about the renoprotective effects of irbesartan in patients with nephropathy due to type 2 diabetes,7\r\n4677,HUNSICKER LG,CLARKE WR,Co-authors on a study about the renoprotective effects of irbesartan in patients with nephropathy due to type 2 diabetes,6\r\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            },\n            {\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }\n        ]\n    }\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nLimit the total report length to 2000 words.\n\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_a7688d4f8169406a51065e4e7f0218b28f42f2ccb75bbbdafc0d035c135abf7e_v2"}